VR Advisory Services’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

VR Advisory Services’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-22,065	Closed	-$7.5K	–	45
2024 Q1	$7.5K	Hold	22,065	–	–	﹤0.01%	30
2023 Q4	$5.08K	Hold	22,065	–	–	﹤0.01%	37
2023 Q3	$3.64K	Hold	22,065	–	–	﹤0.01%	53
2023 Q2	$3.4K	Hold	22,065	–	–	﹤0.01%	55
2023 Q1	$2.16K	Hold	22,065	–	–	﹤0.01%	65
2022 Q4	$1.32K	Hold	22,065	–	–	﹤0.01%	65
2022 Q3	$2K	Hold	22,065	–	–	﹤0.01%	79
2022 Q2	$2K	Hold	22,065	–	–	﹤0.01%	64
2022 Q1	$8K	Hold	22,065	–	–	﹤0.01%	71
2021 Q4	$13K	Buy	+22,065	New	+$14.8K	0.01%	67

Other funds holding AONCW

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $190M AUM 31.84% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

VR Advisory Services's AONCW Position: Q2 2024 in Review

VR Advisory Services sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 22,065 shares — an estimated $7.5K sold.

VR Advisory Services first reported a position in AONCW in Q4 2021 and held it in 10 quarters. The position peaked at $13K in Q4 2021. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

VR Advisory Services reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
VR Advisory Services sold 22,065 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $7.5K.
VR Advisory Services first reported a position in American Oncology Network, Inc. Warrant in Q4 2021 and held it in 10 quarters.
VR Advisory Services's American Oncology Network, Inc. Warrant position peaked at $13K in Q4 2021.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on VR Advisory Services's 13F filing for Q2 2024, filed 14 Aug 2024.